Can Akebia Therapeutics Inc (AKBA) Stock Rise to the Top of Healthcare Sector Thursday?

Akebia Therapeutics Inc (AKBA) is near the top in its sector according to InvestorsObserver. AKBA gets an overall rating of 99. That means it scores higher than 99% of stocks. Akebia Therapeutics Inc gets a 100 rank in the Healthcare sector. Healthcare is number 1 out of 11 sectors.

AKBA has an Overall Score of 99. Find out what this means to you and get the rest of the rankings on AKBA!

See Full AKBA Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Akebia Therapeutics Inc Stock Today?

Akebia Therapeutics Inc (AKBA) stock has fallen -2.75% while the S&P 500 has gained 0.1% as of 9:39 AM on Thursday, Mar 28. AKBA has fallen -$0.06 from the previous closing price of $2.24 on volume of 14,545,590 shares. Over the past year the S&P 500 is higher by 30.43% while AKBA has gained 257.38%. AKBA lost -$0.28 per share the over the last 12 months. Click Here to get the full Stock Report for Akebia Therapeutics Inc stock.